Abstract
Low-risk gestational trophoblastic neoplasia (GTN) can be effectively treated by chemotherapy with a single agent, which is usually methotrexate (MTX) associated with folinic acid (FA) as it is less toxic than MTX or actinomycin D alone. There are no studies comparing treatment outcomes among regional centers with different socioeconomic characteristics and different treatment settings. O…